Search
27388 results found for *.
-
TrumpCare's Tax Gift to Pharma Raises Premiums By Billions in Medicare Part B
-
Wyden Raises Concerns After Reports that Fired U.S. Attorney Was Investigating Tom Price’s Stock Trades
-
Wyden Asks HHS to Ensure Verma Complies with Ethics Agreement
-
Wyden Slams Republican Vote to Create “Bedlam” for Drug Testing of Unemployed Americans
-
Wyden and Pallone to Price: No Authority to Approve Harmful Medicaid Waivers
-
Wyden Calls for Increased Drug Pricing Transparency to Lower Costs
-
Hearing to Consider the Nomination of Robert Lighthizer, of Florida, to be United States Trade Representative, with the rank of Ambassador Extraordinary and Plenipotentiary
-
Wyden Statement at Finance Committee Hearing on Lighthizer Nomination for USTR
-
Hatch Statement at Finance Confirmation Hearing for USTR
-
Hatch Urges Support for Rollback of Narrowly Written DOL Drug Screening Rule